Dequalinium (Fluomizin Vaginal)
Dequalinium
Adcock ingram limited
Registration
- Applicant
- Adcock ingram limited
- Certificate holder
- Adcock ingram limited
- Registrations
- 1
Variants
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S2: Dequalinium
- when intended for human vaginal use;
- except when intended for oral topical use, as oral solutions or lozenges (S1)
Consolidated Schedules 06 July 2026, lines 1791 to 1795
S1: Dequalinium
- when intended for oral topical use, as oral solutions or lozenges;
- except when intended for human vaginal use. (S2)
Consolidated Schedules 06 July 2026, lines 359 to 363
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
1-[10-(4-Amino-2-methylquinolin-1-ium-1-yl)decyl]-2-methylquinolin-1-ium-4-amine
Drag to rotate. Structure from PubChem CID 2993.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.